Adenosine
"Adenosine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A nucleoside that is composed of adenine and d-ribose. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter.
Descriptor ID |
D000241
|
MeSH Number(s) |
D03.438.759.590.138 D13.570.583.138 D13.570.800.096
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Adenosine".
Below are MeSH descriptors whose meaning is more specific than "Adenosine".
This graph shows the total number of publications written about "Adenosine" by people in UAMS Profiles by year, and whether "Adenosine" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2023 | 0 | 3 | 3 | 2022 | 0 | 1 | 1 | 2019 | 0 | 1 | 1 | 2018 | 3 | 0 | 3 | 2017 | 1 | 0 | 1 | 2016 | 1 | 2 | 3 | 2015 | 0 | 1 | 1 | 2014 | 1 | 0 | 1 | 2013 | 0 | 1 | 1 | 2012 | 1 | 2 | 3 | 2011 | 2 | 0 | 2 | 2009 | 3 | 0 | 3 | 2008 | 0 | 1 | 1 | 2007 | 2 | 1 | 3 | 2006 | 2 | 0 | 2 | 2005 | 0 | 1 | 1 | 2004 | 0 | 2 | 2 | 2002 | 0 | 1 | 1 | 2001 | 0 | 1 | 1 | 1997 | 0 | 1 | 1 | 1996 | 0 | 1 | 1 | 1994 | 0 | 1 | 1 | 1993 | 1 | 1 | 2 | 1992 | 0 | 1 | 1 | 1990 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Adenosine" by people in Profiles over the past ten years.
-
Dranoff JA. Coffee, adenosine, and the liver. Purinergic Signal. 2024 02; 20(1):21-28.
-
Wang G, Zeng D, Sweren E, Miao Y, Chen R, Chen J, Wang J, Liao W, Hu Z, Kang S, Garza LA. N6-methyladenosine RNA Methylation Correlates with Immune Microenvironment and Immunotherapy Response of Melanoma. J Invest Dermatol. 2023 08; 143(8):1579-1590.e5.
-
Jain N, Corken A, Arthur JM, Ware J, Arulprakash N, Dai J, Phadnis MA, Davis O, Rahmatallah Y, Mehta JL, Hedayati SS, Smyth S. Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease. Vascul Pharmacol. 2023 02; 148:107143.
-
Deng LJ, Deng WQ, Fan SR, Chen MF, Qi M, Lyu WY, Qi Q, Tiwari AK, Chen JX, Zhang DM, Chen ZS. m6A modification: recent advances, anticancer targeted drug discovery and beyond. Mol Cancer. 2022 02 14; 21(1):52.
-
Obeidat OS, Alhouri A, Baniissa B, Alqaisi O, Akkawi M, Zyad H, Alrimawi O, Al Jabi M, Jaradat S, Jawabreh H, Al-Batsh O, Alaraj O, Juweid ME. Prognostic significance of post-stress reduction in left ventricular ejection fraction with adenosine stress in Jordanian patients with normal myocardial perfusion. J Nucl Cardiol. 2020 10; 27(5):1596-1606.
-
Uddin MB, Roy KR, Hosain SB, Khiste SK, Hill RA, Jois SD, Zhao Y, Tackett AJ, Liu YY. An N6-methyladenosine at the transited codon 273 of p53 pre-mRNA promotes the expression of R273H mutant protein and drug resistance of cancer cells. Biochem Pharmacol. 2019 02; 160:134-145.
-
Fausther M. Extracellular adenosine: a critical signal in liver fibrosis. Am J Physiol Gastrointest Liver Physiol. 2018 07 01; 315(1):G12-G19.
-
Pothineni NVK, Edupuganti MM, Almomani A, Payne J, Raina S, Fnu S, Abualsuod A, Wong J, Uretsky BF, Hakeem A. Comparison of the prognostic value of non-ischaemic fractional flow reserve using intracoronary versus intravenous adenosine. EuroIntervention. 2018 02 20; 13(14):1680-1687.
-
Lavoie EG, Fausther M, Goree JR, Dranoff JA. The Cholangiocyte Adenosine-IL-6 Axis Regulates Survival During Biliary Cirrhosis. Gene Expr. 2017 11 27; 17(4):327-340.
-
Agarwal SK, Kasula S, Almomani A, Hacioglu Y, Ahmed Z, Uretsky BF, Hakeem A. Clinical and angiographic predictors of persistently ischemic fractional flow reserve after percutaneous revascularization. Am Heart J. 2017 02; 184:10-16.
-
Brice AE, Hernandez GA, Sanchez M, Haynick M, Mendoza CE. In-stent thrombosis when switching ticagrelor to clopidogrel after percutaneous coronary intervention. Platelets. 2017 May; 28(3):305-309.
-
Jain N, Reilly RF. Oral P2Y12 Receptor Inhibitors in Hemodialysis Patients Undergoing Percutaneous Coronary Interventions: Current?Knowledge and Future Directions. Semin Dial. 2016 09; 29(5):374-81.
-
Hakeem A, Garg A, Bhatti S, Ahmed Z, Uretsky BF. Fractional flow reserve in acute coronary syndrome: a word of caution. EuroIntervention. 2015 Dec; 11(8):e1-2.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|